Tendinopathy: injury, repair, and current exploration #MMPMID29593382
Lipman K; Wang C; Ting K; Soo C; Zheng Z
Drug Des Devel Ther 2018[]; 12 (ä): 591-603 PMID29593382show ga
Both acute and chronic tendinopathy result in high morbidity, requiring management that is often lengthy and expensive. However, limited and conflicting scientific evidence surrounding current management options has presented a challenge when trying to identify the best treatment for tendinopathy. As a result of shortcomings of current treatments, response to available therapies is often poor, resulting in frustration in both patients and physicians. Due to a lack of understanding of basic tendon-cell biology, further scientific investigation is needed in the field for the development of biological solutions. Optimization of new delivery systems and therapies that spatially and temporally mimic normal tendon physiology hold promise for clinical application. This review focuses on the clinical importance of tendinopathy, the structure of healthy tendons, tendon injury, and healing, and a discussion of current approaches for treatment that highlight the need for the development of new nonsurgical interventions.
free
free
free
Drug+Des+Devel+Ther 2018 ; 12 (ä): 591-603
